Scientists are pioneering a revolutionary cell therapy that could make the current treatments of autoimmune diseases such as Crohn’s disease and multiple sclerosis obsolete: Led by Professor Ye Htun Oo at the University of Birmingham, the project uses a patient’s own regulatory T cells to retrain the immune system, combating harmful autoimmune responses which lead to organ failure. This innovative approach may soon replace traditional treatments which often cause serious side effects such as hypertension, diabetes, and cancer risk. With more than 8,000 people currently awaiting transplants in the UK, and each procedure costing up to £100,000, the potential savings to the NHS are immense. The therapy, expected to be available within a decade, could transform the treatment of autoimmune liver disease and related conditions, offering hope for longer, healthier lives without dependency on harsh medications. While further trials are needed, experts describe this research as a ‘game-changer’ for modern medicine.